Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to discuss 2 stocks that im buying in this market.

2 extracted signals · 2 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor05 Feb 2026, 00:16 UTC
Video preview for Friends! In this video, I'm going to discuss 2 stocks that im buying in this market.
Signals
2
Eligible signals in this source
Open
0
Still being tracked
Resolved
2
Evaluable outcomes
Successful
0
Canonical correct result
Failed
2
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The speaker is bullish on Microsoft (MSFT) and Meta (META), believing both stocks are undervalued and poised for growth. For MSFT, the analysis focuses on historical P/E ratios and future growth projections, suggesting a target price of $844.77 with a potential 110% upside. For META, the speaker highlights strong revenue and user growth, coupled with a reasonable valuation, leading to a positive outlook. The speaker's investment strategy involves dollar-cost averaging into these positions during market downturns.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  4. Market predictions extracted

    2 eligible signals linked to this case.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.